# A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia

> **NCT05002192** · — · UNKNOWN · sponsor: **Beijing Grand Johamu Pharmaceutical Company, Ltd.** · enrollment: 10000 (estimated)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DRUG:** Eucalyptol, Limonene and Pinene Enteric Soft Capsule
- **DRUG:** Ambroxol injection
- **DRUG:** Other oral mucolytic drugs

## Key facts

- **NCT ID:** NCT05002192
- **Lead sponsor:** Beijing Grand Johamu Pharmaceutical Company, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2021-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05002192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05002192, "A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05002192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*